Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Ping An Makes Breakthrough in Artificial Intelligence-Driven Drug Research
Research by Ping An Healthcare Technology Research Institute and Tsinghua University has led to a […]
Nuevocor Closes US$24M Series A Financing to Advance Novel Gene Therapies for Cardiomyopathies
Nuevocor, a preclinical-stage biotech company specializing in gene therapy for cardiomyopathies, has announced the completion […]
Leading Social Media Platforms Unite to Support COVID-19 Vaccine Drive
Collaboration comes as all adults aged 18 and over invited to get a jab Filters […]
Over One Million Jabs Booked as NHS Vaccine Programme Opens to All Adults
More than one million jab appointments were booked since the NHS vaccination programme opened for […]
CureDuchenne Launches Next-generation Data-sharing Platform to Accelerate a Cure for Duchenne and Becker Muscular Dystrophy
CureDuchenne, a leading global nonprofit focused on finding and funding a cure for Duchenne muscular […]
Mnemo Therapeutics Announces €75 million Series A to Accelerate Next Generation Integrated CAR-T and Epigenetic Targeting Platform
Mnemo Therapeutics, a biotechnology company developing powerful cell therapies using a novel target identification engine, […]
Medable Hires Sanskriti Thakur as Chief Growth Officer to Lead Market Expansion
Medable Inc., the leading cloud platform for patient-centered drug development, today announced the hiring of Sanskriti […]
Apollo Therapeutics Completes $145 Million Financing Led by Patient Square Capital to Expand and Advance Portfolio-Based Drug Development
Apollo Therapeutics, a portfolio-based biopharmaceutical company rapidly advancing potentially transformative treatments based on breakthrough discoveries, […]
Spring Health Announces Harshit Shah as New Chief Technology Officer
Spring Health, a leading provider of behavioral health benefits with the most comprehensive solution for […]
Vyne Medical Launches Cloud-based Refyne Platform for Healthcare
Vyne Medical today announced the launch of its new Refyne™ platform. Purpose built for healthcare, […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more